LANDP:NASDAQGladstone Land Corporation - 6.00% Series C Cumulative Redeemable Preferred Stock Analysis
Data as of 2026-04-14 - not real-time
$20.07
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Gladstone Land’s price is trading just below its recent resistance while its short‑term averages remain tightly stacked, indicating a bullish technical backdrop. The RSI sits in the upper‑mid range and the MACD histogram is positive, supported by an uptick in volume, suggesting continued upward momentum with limited market correlation as reflected by an exceptionally low beta.
Fundamentally, the REIT delivers robust top‑line growth and healthy margins, and free cash flow remains strong despite a modest earnings profile. A high distribution yield, recent farm sales that generated sizable gains, and a price‑to‑book ratio modestly above one point to attractive income potential, though the balance sheet is heavily levered and return metrics are low, raising questions about long‑term dividend sustainability.
Fundamentally, the REIT delivers robust top‑line growth and healthy margins, and free cash flow remains strong despite a modest earnings profile. A high distribution yield, recent farm sales that generated sizable gains, and a price‑to‑book ratio modestly above one point to attractive income potential, though the balance sheet is heavily levered and return metrics are low, raising questions about long‑term dividend sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators near resistance
- Strong current distribution yield
- Increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Solid free cash flow generation
- Recent asset sales adding cash and reducing risk
- Attractive price relative to book value
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable underlying farmland assets
- High leverage and low profitability
- Potential regulatory and climate exposure
Key Metrics & Analysis
Financial Health
Revenue Growth96.50%
Profit Margin15.32%
ROE1.99%
ROA1.20%
Debt/Equity81.81
P/B Ratio1.1
Op. Cash Flow$7.0M
Free Cash Flow$50.4M
Industry P/E32.9
Technical Analysis
TrendBullish
RSI59.6
Support$19.43
Resistance$20.21
MA 20$19.88
MA 50$19.81
MA 200$19.51
MACDBullish
VolumeIncreasing
Fear & Greed Index87.29
Valuation
GradeUndervalued
TypeBlend
Dividend Yield7.51%
Risk Assessment
Beta0.04
Volatility8.14%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.